HomeCompareEMMF vs JNJ

EMMF vs JNJ: Dividend Comparison 2026

EMMF yields 2.25% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EMMF wins by $3.0K in total portfolio value
10 years
EMMF
EMMF
● Live price
2.25%
Share price
$33.11
Annual div
$0.74
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$23.0K
Annual income
$259.91
Full EMMF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — EMMF vs JNJ

📍 EMMF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEMMFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EMMF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
EMMF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EMMF
Annual income on $10K today (after 15% tax)
$191.06/yr
After 10yr DRIP, annual income (after tax)
$220.92/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $482.69/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EMMF + JNJ for your $10,000?

EMMF: 50%JNJ: 50%
100% JNJ50/50100% EMMF
Portfolio after 10yr
$21.5K
Annual income
$543.85/yr
Blended yield
2.53%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

EMMF
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EMMF buys
0
JNJ buys
0
No recent congressional trades found for EMMF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEMMFJNJ
Forward yield2.25%3.36%
Annual dividend / share$0.74$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$23.0K$20.0K
Annual income after 10y$259.91$827.78
Total dividends collected$2.4K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: EMMF vs JNJ ($10,000, DRIP)

YearEMMF PortfolioEMMF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,925$224.78$10,676$355.77+$249.00EMMF
2$11,919$229.50$11,407$389.39+$512.00EMMF
3$12,987$234.00$12,198$426.53+$789.00EMMF
4$14,135$238.30$13,056$467.62+$1.1KEMMF
5$15,367$242.38$13,987$513.12+$1.4KEMMF
6$16,688$246.27$14,998$563.56+$1.7KEMMF
7$18,107$249.96$16,098$619.52+$2.0KEMMF
8$19,628$253.46$17,295$681.69+$2.3KEMMF
9$21,258$256.77$18,599$750.82+$2.7KEMMF
10$23,006$259.91$20,022$827.78+$3.0KEMMF

EMMF vs JNJ: Complete Analysis 2026

EMMFStock

The fund, an exchange traded fund ("ETF"), is actively managed using a model-based approach. Under normal circumstances, it will invest at least 80% of its net assets in equity securities of emerging markets. The advisor generally expects to invest in large- and mid-capitalization companies, but it may also invest in small-capitalization companies. The fund is non-diversified.

Full EMMF Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this EMMF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EMMF vs SCHDEMMF vs JEPIEMMF vs OEMMF vs KOEMMF vs MAINEMMF vs ABBVEMMF vs MRKEMMF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.